Patient Relations
Cervical cancer screening is critical for early detection and involves two main tests: Pap smear and HPV (Human Papillomavirus) testing.
The Pap smear checks for precancerous or cancerous cells in the cervix, while HPV testing identifies the virus that can cause these cells to change. Both tests are usually done during the same visit and involve collecting cells from the cervix for laboratory analysis. The procedure is typically completed in a few minutes.
Regular screening is recommended for women aged 21-64. Talk to your JHAH obstetrician who will go over the personal and family history you provided to determine if you might want to screen at a younger age.
When treated early, there is a high success rate. Studies show that early detection increases survival rates by up to 30% and allows for less aggressive treatment and better disease management.
Persistent HPV infections can lead to cell changes in the cervix, which may develop into cancer if left untreated. There is an HPV vaccine available that provides an additional level of protection.
The HPV vaccination is highly effective in preventing the types of HPV most commonly associated with cervical cancer. The combination of vaccination and regular screenings is a powerful defense against cervical cancer.
JHAH recommends that children age 9-13 receive their first dose of the vaccine. Talk to the child’s pediatric physician about the vaccine during the next appointment for your child.
Schedule today. You will not only be prioritizing your health, you’ll have made an important step toward living a long, healthy life with your loved ones. THE LIFE YOU SAVE MAY BE YOUR OWN.
Access JHAH MyChart anytime, anywhere from your smartphone or computer.
During regular working hours, call 800-305-4444.
